TRRVF yields 0.55% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, TRRVF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TRRVF + PFE for your $10,000?
TerraVest Industries Inc., together with its subsidiaries, manufactures and sells goods and services to energy, agriculture, mining, and transportation markets in Canada and the United States. It operates through three segments: Fuel Containment, Processing Equipment, and Service. The Fuel Containment segment manufactures bulk liquefied petroleum gas (LPG) transport trailers, LPG delivery and service trucks, LPG storage tanks, residential and commercial LPG tanks and dispensers, custom pressure vessels, commercial and residential refined fuel tanks, and furnaces and boilers. This segment sells its products directly to end user, as well as through various distribution networks to fuel distributors, transportation companies, industrial and commercial consumers, and residential consumers. The Processing Equipment segment manufactures and sells a range of equipment, such as wellhead processing equipment and tanks, wellhead desanding units, central facilities processing equipment, natural gas liquids (NGL) and LPG storage tanks, anhydrous ammonia storage tanks, NGL and LPG transport trailers, ammonia transport trailers and wagons, compressed gas transport trailers, and various customized processing equipment. This segment offers its products to oil and gas producers, midstream and engineering companies, propane and fertilizer distributors, and transportation companies. The Service segment provides well servicing to the oil and gas sector in Southwest and Central Saskatchewan. This segment operates 21 service rigs. The company was formerly known as TerraVest Capital Inc. and changed its name to TerraVest Industries Inc. in February 2018. TerraVest Industries Inc. was founded in 2004 and is headquartered in Vegreville, Canada.
Full TRRVF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.